Key statistics
As of last trade Novozymes A/S (NZM2:BRN) traded at 58.65, -0.14% below its 52-week high of 58.73, set on Sep 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 58.73 |
---|---|
High | 58.73 |
Low | 58.65 |
Bid | 58.36 |
Offer | 58.61 |
Previous close | 58.65 |
Average volume | -- |
---|---|
Shares outstanding | 414.56m |
Free float | 295.10m |
P/E (TTM) | 59.20 |
Market cap | 169.94bn DKK |
EPS (TTM) | 6.92 DKK |
Annual div (ADY) | 0.5099 CHF |
---|---|
Annual div yield (ADY) | 0.87% |
Div ex-date | Aug 30 2024 |
Div pay-date | Sep 03 2024 |
Data delayed at least 15 minutes, as of Sep 17 2024.
More ▼
Announcements
- Trading by management and close relations of management
- Novonesis will host an educational conference call on Energy on December 18
- Major shareholder announcement
- Q3 update: Novonesis delivers strong Q3 results and now expects full-year organic sales growth at the upper end of 7-8%
- Trading statement 9M 2024
- New employee-elected board member
- Trading by management and close relations of management
- Novonesis delivers strong half-year results and increases full-year outlook
- Interim Report H1 2024
- Novonesis increases outlook for full year 2024
More ▼